The Noramco Group Invests $25 Million in Halo Pharma’s Whippany Facility to Offer Sterile Injectable Manufacturing
Press Release The Noramco Group, an integrated North American-based API and drug product supply chain product and services provider, today announced a $25 million investment in its Halo Pharma ...
Contract Pharma13d
The Noramco Group Invests $25M into Halo Pharma Facility in NJ
The Noramco Group is investing $25M into its Halo Pharma facility in Whippany, NJ to establish sterile injectable ...
Pharmabiz1mon
Orchid Pharma's Alathur API facility successfully completes US FDA inspection
Orchid Pharma Ltd., a vertically integrated pharmaceutical company spanning the entire pharmaceutical value chain from discovery to delivery, announced the successful completion of a surprise US Food ...
Business Wire13d
The Noramco Group Invests $25 Million in Halo Pharma’s Whippany Facility to Offer Sterile Injectable Manufacturing
an integrated North American-based API and drug product supply chain product and services provider, today announced a $25 million investment in its Halo Pharma facility in Whippany, New Jersey ...